pCH043
(Plasmid
#47949)
-
PurposertTA under the control of GAL1 promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 47949 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRS306
-
Backbone manufacturerATCC
- Total vector size (bp) 4373
-
Vector typeYeast Expression ; Tet inducible expression
-
Selectable markersURA3
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namertTA
- Promoter Gal1
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer Gal1_primer (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
TetR is downstream of Gal1 promoter.
The expression in these constructs is driven by tet operators. The GAL1 promoter contains a mutation in the proximal Gal4 BS to have only three Gal4 binding sites. Since the above plasmids (pCH043, pSS63, pPR184) can be used only in delGal4 strains, this does not affect the basal expression in these constructs.
The discrepancies found between the Addgene QC sequence and the full sequence do not affect the functioning of the construct.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCH043 was a gift from Attila Becskei (Addgene plasmid # 47949 ; http://n2t.net/addgene:47949 ; RRID:Addgene_47949) -
For your References section:
Stochastic signalling rewires the interaction map of a multiple feedback network during yeast evolution. Hsu C, Scherrer S, Buetti-Dinh A, Ratna P, Pizzolato J, Jaquet V, Becskei A. Nat Commun. 2012 Feb 21;3:682. doi: 10.1038/ncomms1687. 10.1038/ncomms1687 PubMed 22353713